In recent years, radiation dose management awareness has heightened across the healthcare industry to address growing ...
For all the benefits of medical imaging, most forms come with the inherent danger of radiation exposure. Public ...
June 12, 2017 โ Abiomed Inc. recently released its third-generation Impella CP heart pump at the 2017 meeting of the ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
June 12, 2017 โ Med Alliance announced completion on schedule of patient enrollment in the first-in-man (FIM) study of ...
June 12, 2017 โ TandemLife began its commercial launch of the TandemLife Priming Tray, a new product designed to ...
June 12, 2017 โ Heart muscle is one of the least renewable tissues in the body, which is one of the reasons that heart ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
June 12, 2017 โ A study using strain imaging presented at the American Society of Echocardiography (ASE) 2017 ...
June 12, 2017 โ The Medtronic Resolute Onyx Drug-Eluting Stent (DES) met its primary endpoint of target lesion failure ...
June 5, 2017 โ The U.S. Food and Drug Administration (FDA) granted market clearance for the Claret Medical Sentinel ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Chi-Ming Chow, M.D., MSc, FRCPC, FACC, FASE, attending staff cardiologist, St. Michael's Hospital, and associate professor, Department of Medicine, University of Toronto, discusses new technology trends in ultrasound and what developments will effect the future of cardiac ultrasound.
Andrea Natale, M.D., FACC, FHRS, FESC, executive medical director, Texas Cardiac Arrhythmia Institute at St. David's ...
The U.S. Food and Drug Administration (FDA) has granted market clearance for aortic and mitral valve-in-valve procedures using the Edwards Lifesciences Sapien 3 transcatheter heart valve (THV). The Sapien 3 valve is the first transcatheter heart valve approved in the U.S. for the treatment of both aortic and mitral patients who are at high risk for a subsequent open-heart surgery to replace their bioprosthetic valve.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
June 1, 2017 โ More than 50 companies and organizations will display their latest products and services at the American ...
June 1, 2017 โ Here is the list of the most popular pieces of content on the Diagnostic and Interventional Cardiology ...
Northwell Health recently announced a new partnership agreement with Peerbridge Health Inc., to explore the future of remote medical monitoring. Peerbridge technology enables remote patient monitoring through multiple on-body wireless sensors.